Sign Out
Montelukast (Montela) is indicated for: The prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.
It is indicated for the prevention of exercise-induced bronchoconstriction (EIB) in patients 15 years of age and older.
It is also indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older.
Continue with Google